Cory Renauer
Cory Renauer is a contributing Motley Fool healthcare analyst covering pharmaceuticals, biotechnology, and medical devices. Previously, Cory was a laboratory technician for the American Red Cross. He holds a bachelor’s degree in biology from Oakland University.
Recent Articles by Cory Renauer

May 24, 2025
by Cory Renauer
Does the 23andMe Acquisition Make Regeneron a Buy Now?

May 16, 2025
by Cory Renauer
Down 59%, Is UnitedHealth Group Stock a Buy on the Dip?

May 1, 2025
by Cory Renauer
Is Sofi Technologies Stock a Buy Now?

Apr 22, 2025
by Cory Renauer
Is Beaten-Down Coupang Stock a Buy on the Dip?
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.